COMPANY

Bedrock Therapeutics

HQ: Chapel Hill, NC source · bedrocktherapeutics.com ↗

Bedrock Therapeutics has received NIH funding, most recently in fiscal 2025 for the project “Intramuscular Administration of AAV Vectors Encoding soluble PD-L1 for Rheumatoid Arthritis Treatment”. From public records Source · Oct 12, 2026

Keywords: From press sources: gene therapy AAV rheumatoid arthritis

Profile checked Oct 10, 2026